Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 12
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II/III Combination Chemotherapy with AMSA/ARA-C for Reinduction and AMSA/VP-16 for Maintenance in Children with Relapsed ANLL
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
under 22
NCI
CCG-201
2.
Phase III Reinduction with ARA-C/DNM vs CYC/DNM and Maintenance with ARA-C/CTX vs CYC/CTX for Acute Nonlymphocytic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
under 20
NCI
CCG-243
Last Modified:
8/10/2007
3.
Phase III Pilot Study of Induction Chemotherapy with VPL (VCR/PRED/L-ASP), Salvage of Induction Failures with High-Dose ARA-C/L-ASP, and Intensification/Maintenance with ARA-C/ADR/L-ASP/PRED/VCR/MTX vs ARA-C/TBI/Allogeneic BMT in Children with Relapsed ALL
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
under 18
NCI
CCG-181P
Last Modified:
5/2/2007
4.
Phase I-II Chemotherapy with Cyclocytidine for Refractory Acute Leukemia, Lymphomas and Solid Tumors in Children
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
under 21
NCI
POG-7516
5.
Phase II Pilot Study of Chemotherapy with DBD/CYC for Metastatic Malignant Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI-D81-032-301
6.
Phase II Chemotherapy with Cyclocytidine for Primary or Recurrent Breast Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
SWOG-7437
7.
Phase II Study of Single-Agent Chemotherapy with Cyclocytidine for Disseminated Malignant Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
SWOG-7504
8.
Phase II Chemotherapy with Cyclocytidine for Children with Acute Leukemia and Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
under 18
NCI
CCG-051
9.
Phase II Pilot Study of Induction with CYC/AMSA and Maintenance with VP-16/AMSA for Pediatric Acute Leukemia or CML in Blastic Crisis in Relapse
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
under 15
MSKCC-8143
10.
ROAP - Rubidazone/VCR/ARA-C/PRED plus MER-BCG Immunotherapy for Acute Nonlymphocytic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Closed
over 50
MDA-DT-7635A
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute